Evaluation of Mean Percentage of Full-Length SMN Transcripts as a Molecular Biomarker of Spinal Muscular Atrophy

The elevation of SMN transcript and protein level remains the principal aim of SMA therapy. Still, there is no standard molecular biomarker for the assessment of its efficacy. In the current study, we tested three methods of SMN transcript level measurement using real-time RT-PCR, quantitative fluor...

Descripción completa

Detalles Bibliográficos
Autores principales: Maretina, Marianna, Egorova, Anna, Lanko, Kristina, Baranov, Vladislav, Kiselev, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602009/
https://www.ncbi.nlm.nih.gov/pubmed/36292797
http://dx.doi.org/10.3390/genes13101911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602009/
https://www.ncbi.nlm.nih.gov/pubmed/36292797
http://dx.doi.org/10.3390/genes13101911

Ejemplares similares